Fosalvudine Tidoxil

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFosalvudine Tidoxil
Drug Alias Name磷夫定酯fosalvudine tidoxil福沙夫定替酯fosalvudina tidoxilofosalvudinum tidoxilum +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHeidelberg Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHeidelberg Pharma AG
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A